| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech, Inc. (EDSA) has 9 insiders with recent SEC Form 4 filings, including 4 buys and 10 sells. EDSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 501.8K | $3.07M | - | |
| Pres | 226.9K | $1.39M | - | |
| CFO | 65.0K | $397.8K | - | |
| Dir | 52.7K | $322.3K | - | |
| Dir | 30.4K | $186.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2020 | Brooks Michael J | President | Buy | 1,827 | $4.11 | $7,508.97 | New | |
| Jan 8, 2020 | Sistilli Carlo | Director | Buy | 2,436 | $4.11 | $10,011.96 | New | |
| Jan 8, 2020 | Van Der Velden Peter | Director, 10% Owner | Buy | 140,625 | $3.20 | $450,000.00 | +7.6% | |
| Sep 11, 2019 | Oakes Frank R. | Director | Sell | 1,809 | $5.72 | $10,345.13 | -22.7% | |
| Mar 6, 2019 | Oakes Frank R. | President &CEO | Sell | 4,000 | $1.25 | $5,000.40 | -7.7% | |
| Oct 12, 2018 | Oakes Frank R. | President &CEO | Sell | 3,000 | $1.31 | $3,930.00 | -5.5% | |
| Oct 12, 2018 | Morse Daniel E. | Former Director | Sell | 7,047 | $1.31 | $9,259.76 | -25.4% | |
| Mar 29, 2018 | Morse Daniel E. | Director | Sell | 4,366 | $0.81 | $3,514.63 | -100% | |
| Mar 12, 2018 | Morse Daniel E. | Director | Sell | 32,300 | $0.79 | $25,599.70 | -29.3% |